Bio-Techne Corporation has announced the expanded launch and first shipment of its next-generation Leo™ System, an advanced protein analysis platform powered by Simple Western™ Technology. The enhanced Leo System features dual-channel fluorescence and chemiluminescence detection, enabling researchers to analyze up to 24 protein targets per sample and process up to 100 capillaries within three hours. This investment in high-throughput, multiplexed protein analysis strengthens Bio-Techne's leadership in proteomic analytical instruments and supports compliance with 21 CFR Part 11. The new system is designed to accelerate research workflows and provide highly precise results, expanding Bio-Techne's capabilities in the life sciences sector.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bio-Techne Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: CG41626) on December 09, 2025, and is solely responsible for the information contained therein.
Comments